Dr. Bellairs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34612 6TH AVE S
Federal Way, WA 98003
Summary
- I am a board-eligible otolaryngologist specializing in comprehensive ear, nose, and throat (ENT) care. I completed my residency in Otolaryngology and Head and Neck Surgery at the University of Washington. I am dedicated to diagnosing and treating a wide range of ENT conditions in patients of all ages, from children to adults, ensuring that each patient receives personalized care tailored to their unique needs.
Education & Training
- University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2017 - 2024
- University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2024
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2017
Certifications & Licensure
- WA State Medical License 2019 - 2026
Publications & Presentations
PubMed
- Benign Follicular Hyperplasia With Clonal B Cell Expansion: An Uncommon Differential to Unilateral Tonsillar Enlargement.Joseph A Bellairs, Shengyan K Yu, Zhao Ming Dong, Zain H Rizvi
Ear, Nose, & Throat Journal. 2023-06-26 - 2 citationsAnBiomarker to Characterize Ototoxic Compounds and Novel Protective Therapeutics.Joseph A Bellairs, Van A Redila, Patricia Wu, Ling Tong, Alyssa Webster
Frontiers in Molecular Neuroscience. 2022-01-01 - 9 citationsActivating the Intrinsic Pathway of Apoptosis Using BIM BH3 Peptides Delivered by Peptide Amphiphiles with Endosomal ReleaseMathew R. Schnorenberg, Joseph A. Bellairs, Ravand Samaeekia, Handan Acar, Matthew Tirrell
Materials. 2019-08-12
Authored Content
- Genomic Applications in Head and Neck CancerDecember 2018
Research History
- Medical Student Research - University of ChicagoMentor: James L. LaBelle, MD, PhD “BIM BH3 peptide amphiphiles are potent inducers of cellular apoptosis.” - Generated novel peptide amphiphiles with BCL-2 family signaling peptides to modulate apoptosis and cell death pathways in malignant cancer cells2014 - 2017
- Laboratory Research Technician - Dana FarberMentor: Loren D. Walensky, M.D., Ph.D. • Lead research efforts to characterize and further optimize BAM7, a small molecule activator of the proapoptotic BCL-2 family protein BAX. • Piloted In Vivo experiments to validate BAX Activator Molecules (BAMs) as novel therapeutic strategies2011 - 2013
- Research Technician - Memorial Sloan KetteringMentor: Sean Carlin, Ph.D. · Investigated expression patterns of hypoxia regulated genes in cancer cell cultures using qRT-PCR · Optimized RNA extraction, reverse transcription step and SYBR-green based qPCR array techniques for hypoxia regulated genes2010 - 2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: